• TurtleTree Labs raises US$3.2 million seed round as it accelerates cell-based milk development

    SINGAPORE, June 25, 2020 /PRNewswire/ — Singapore-based biotech company TurtleTree Labs today announced the completion of a fresh round of funding from global investors. TurtleTree Labs is the world’s first-cell based biotechnology company creating real milk from mammalian cells, without the need for animals. As a platform, the company’s focus is on high value human breast milk followed by cow milk.


    TurtleTree Labs Founders Max Rye and Fengru Lin

    Over the past year TurtleTree Labs has attracted world class talent, currently boasting a team of more than 20 full-time scientists and engineers. With multiple cross-functional teams working in

    Read More